Minerva Neurosciences | NERV - Pe Kurs-Gewinn

Aktienkurs
6.37
Täglich Wechseln
0.33 5.46%
Monatlich
2.25%
Jährlich
241.56%
Q1 Prognose
7.31




Pe Veränderung Datum
Acadia Pharmaceuticals 11.61 2.09 2025-12
Adma Biologics 29.73 12.48 2025-12
ALKERMES 19.54 4.64 2025-12
AstraZeneca 27.29 5.8 2025-12
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Cipla 27.74 3.55 2025-12
Clal Biotechnology 11.67 2.62 2022-12
Compugen 4.06 75.75 2025-12
CSL 16.16 9.59 2025-12
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
GlaxoSmithKline 11.15 0.29 2025-12
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 23.16 7.7 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 23.62 0.86 2025-12
Merck 13.92 5.08 2025-12
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 17.85 2.11 2025-12
Novavax 2.01 1.07 2025-12
Pfizer 14.48 5.18 2025-12
Roche Holding 16.09 3.51 2025-12
Sanofi 11.99 1.58 2025-12
Takeda 235.05 184.95 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06